The Chemours Company reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was USD 1,538 million compared to USD 1,643 million a year ago. Sales was USD 1,538 million compared to USD 1,643 million a year ago. Net income was USD 70 million compared to net loss of USD 376 million a year ago. Net income was USD 70 million compared to net loss of USD 376 million a year ago. Basic earnings per share from continuing operations was USD 0.47 compared to basic loss per share from continuing operations of USD 2.52 a year ago. Basic earnings per share from continuing operations was USD 0.47 compared to basic loss per share from continuing operations of USD 2.52 a year ago. Diluted earnings per share from continuing operations was USD 0.46 compared to diluted loss per share from continuing operations of USD 2.52 a year ago. Diluted earnings per share from continuing operations was USD 0.46 compared to diluted loss per share from continuing operations of USD 2.52 a year ago.
For the six months, sales was USD 2,887 million compared to USD 3,179 million a year ago. Sales was USD 2,887 million compared to USD 3,179 million a year ago. Net income was USD 121 million compared to net loss of USD 231 million a year ago. Net income was USD 121 million compared to net loss of USD 231 million a year ago. Basic earnings per share from continuing operations was USD 0.81 compared to basic loss per share from continuing operations of USD 1.55 a year ago. Basic earnings per share from continuing operations was USD 0.81 compared to basic loss per share from continuing operations of USD 1.55 a year ago. Diluted earnings per share from continuing operations was USD 0.81 compared to diluted loss per share from continuing operations of USD 1.55 a year ago. Diluted earnings per share from continuing operations was USD 0.81 compared to diluted loss per share from continuing operations of USD 1.55 a year ago.